RU94022269A - Состав аэрозоля, находящийся под давлением - Google Patents
Состав аэрозоля, находящийся под давлениемInfo
- Publication number
- RU94022269A RU94022269A RU94022269/14A RU94022269A RU94022269A RU 94022269 A RU94022269 A RU 94022269A RU 94022269/14 A RU94022269/14 A RU 94022269/14A RU 94022269 A RU94022269 A RU 94022269A RU 94022269 A RU94022269 A RU 94022269A
- Authority
- RU
- Russia
- Prior art keywords
- aerosol composition
- under pressure
- composition under
- units
- hydrofluoroalkane
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title claims 4
- 239000000203 mixture Substances 0.000 title claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229940079593 drugs Drugs 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920000180 Alkyd Polymers 0.000 claims 1
- 125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
Claims (1)
- Изобретение относится к составам аэрозолей, находящимся под давлением, в частности к медикаментам для ингаляции. Состав аэрозоля содержит сжиженный гидрофтороалкан, диспергируемый в нем порошкообразный медикамент и растворимый в указанном гидрофтороалкане полимер, причем полимер включает в себя повторяющиеся структурные единицы, представляющие собой алкидосодержащие единицы и единицы, содержащие сложный эфир карбоновой кислоты. Задачей настоящего изобретения являлось создание экологически чистого состава аэрозоля, в котором поддерживается необходимое для надежной работы давление и обеспечивается хорошая растворимость и стабилизация лекарственных препаратов.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919120396A GB9120396D0 (en) | 1991-09-25 | 1991-09-25 | Formulations |
GB9120396.8 | 1991-09-25 | ||
GB919120675A GB9120675D0 (en) | 1991-09-28 | 1991-09-28 | Formulation |
GB9120675.5 | 1991-09-28 | ||
GB9124661.1 | 1991-11-19 | ||
GB919124661A GB9124661D0 (en) | 1991-11-19 | 1991-11-19 | Formulations |
GB929203212A GB9203212D0 (en) | 1992-02-14 | 1992-02-14 | Pharmaceutical formulations |
GB9203212.7 | 1992-02-14 | ||
PCT/GB1992/001749 WO1993005765A1 (en) | 1991-09-25 | 1992-09-23 | Pressurised aerosol compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94022269A true RU94022269A (ru) | 1995-11-10 |
RU2122852C1 RU2122852C1 (ru) | 1998-12-10 |
Family
ID=27450754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94022269/14A RU2122852C1 (ru) | 1991-09-25 | 1992-09-23 | Состав аэрозоля, находящийся под давлением |
Country Status (29)
Country | Link |
---|---|
US (1) | US6641800B1 (ru) |
EP (2) | EP0534731A1 (ru) |
JP (1) | JP3142136B2 (ru) |
KR (1) | KR100275426B1 (ru) |
CN (1) | CN1050285C (ru) |
AT (1) | ATE132739T1 (ru) |
AU (1) | AU654397B2 (ru) |
BG (1) | BG61752B1 (ru) |
BR (1) | BR9206549A (ru) |
CA (1) | CA2119932C (ru) |
CZ (1) | CZ282506B6 (ru) |
DE (1) | DE69207606T3 (ru) |
DK (1) | DK0605578T4 (ru) |
ES (1) | ES2082507T5 (ru) |
FI (1) | FI110407B (ru) |
GR (2) | GR3019098T3 (ru) |
HK (1) | HK1005564A1 (ru) |
HU (2) | HUT67480A (ru) |
IL (1) | IL103238A (ru) |
MX (1) | MX9205483A (ru) |
MY (1) | MY108309A (ru) |
NO (1) | NO307124B1 (ru) |
NZ (1) | NZ244439A (ru) |
RO (1) | RO114735B1 (ru) |
RU (1) | RU2122852C1 (ru) |
SK (1) | SK279456B6 (ru) |
TW (1) | TW216442B (ru) |
UA (1) | UA41873C2 (ru) |
WO (1) | WO1993005765A1 (ru) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
GB9214819D0 (en) * | 1992-07-13 | 1992-08-26 | Minnesota Mining & Mfg | Valve assemblies |
EP0689423B1 (en) * | 1993-03-17 | 1997-09-17 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing a diol-diacid derived dispersing aid |
US5569450A (en) * | 1993-03-17 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
KR100392280B1 (ko) | 1995-06-27 | 2003-11-19 | 베링거 인겔하임 카게 | 추진제비함유흡입성에어로졸을제조하기위한안정한추진제비함유약제학적용액 |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
US6540982B1 (en) * | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
US20030026766A1 (en) * | 2000-04-13 | 2003-02-06 | Mark Sanders | Medicaments for treating respiratory disorders comprising formoterol and fluticasone |
TWI290473B (en) | 2000-05-10 | 2007-12-01 | Alliance Pharma | Phospholipid-based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
SK286694B6 (sk) | 2000-05-22 | 2009-03-05 | Chiesi Farmaceutici S.P.A. | Aerosólový farmaceutický prostriedok |
ES2222294T3 (es) | 2001-07-02 | 2005-02-01 | Chiesi Farmaceutici S.P.A. | Formulacion optimizada de tobramicina para administracion en forma de aerosol. |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
PT1458360E (pt) | 2001-12-19 | 2011-07-13 | Novartis Ag | Derivados de indole como agonistas do recetor s1p1 |
US7544177B2 (en) * | 2002-01-24 | 2009-06-09 | The Regents Of The University Of California | Aerosol device to deliver bioactive agent |
SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
US7244742B2 (en) * | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
GB0328630D0 (en) * | 2003-12-10 | 2004-01-14 | Medpharm Ltd | Metered dose inhalation preparations |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
US7994225B2 (en) * | 2004-03-17 | 2011-08-09 | Rempex Pharmaceuticals, Inc. | Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections |
WO2005089738A2 (en) * | 2004-03-17 | 2005-09-29 | Mpex Pharmaceuticals, Inc. | Use and administration of bacterial efflux pump inhibitors |
US20070031343A1 (en) * | 2005-08-04 | 2007-02-08 | Bonfour Charles A Iii | Flavored medicinal inhalant |
FR2895260B1 (fr) * | 2005-12-23 | 2009-02-20 | Servier Lab | Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale |
DE102006017320A1 (de) * | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
US8148377B2 (en) | 2007-02-11 | 2012-04-03 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile |
WO2008152398A2 (en) * | 2007-06-14 | 2008-12-18 | Cipla Limited | Formulations for inhalation |
GB0712454D0 (en) | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
EP2274039A2 (en) | 2008-05-06 | 2011-01-19 | Wilson-Cook Medical Inc. | Apparatus and methods for delivering therapeutic agents |
KR20110096538A (ko) * | 2008-11-04 | 2011-08-30 | 씨아이피엘에이 엘티디. | 약제학적 에어로졸 조성물 |
CA2747390C (en) | 2008-12-23 | 2016-10-04 | Wilson-Cook Medical Inc. | Apparatus and methods for containing and delivering therapeutic agents |
US9101744B2 (en) | 2009-05-29 | 2015-08-11 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
US8118777B2 (en) | 2009-05-29 | 2012-02-21 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
CN102416179B (zh) | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
US9867931B2 (en) | 2013-10-02 | 2018-01-16 | Cook Medical Technologies Llc | Therapeutic agents for delivery using a catheter and pressure source |
GB201402513D0 (en) * | 2014-02-13 | 2014-04-02 | Cardiff Scintigraphics Ltd | Pressurised metered dose inhalers and method of manufacture |
EP3174522A1 (en) | 2014-07-29 | 2017-06-07 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
EP3364943B1 (de) * | 2015-10-23 | 2021-06-23 | Basf Se | Formulierungen mit kontrollierter freisetzung von geruchsstoffen zur dermalen anwendung |
US10702495B2 (en) | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
EP3750528A1 (en) | 2019-06-11 | 2020-12-16 | Nexien Biopharma, Inc. | Compositions for treating dystrophies and myotonia |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US417295A (en) * | 1889-12-17 | Fabriken | ||
AT274245B (de) | 1967-05-17 | 1969-09-10 | Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien | |
US4025635A (en) | 1972-09-06 | 1977-05-24 | Burroughs Wellcome Co. | Cyclic sulphur compounds |
CA1136547A (en) * | 1979-03-08 | 1982-11-30 | Song-Ling Lin | Aerosol anesthetic compositions |
EP0175671A1 (de) | 1984-08-23 | 1986-03-26 | Kuhlemann & Co. | Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung |
DE3775960D1 (de) * | 1986-03-10 | 1992-02-27 | Burghart Kurt | Pharmazeutische zubereitung sowie verfahren zur herstellung derselben. |
ATE60226T1 (de) | 1986-03-10 | 1991-02-15 | Kurt Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung. |
US4752466A (en) | 1987-08-31 | 1988-06-21 | Johnson & Johnson Products, Inc. | Thrombin aerosol |
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
GB8921222D0 (en) | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
IL95952A0 (en) | 1989-10-19 | 1991-07-18 | Sterling Drug Inc | Aerosol composition for topical medicament |
IE67185B1 (en) | 1990-02-02 | 1996-03-06 | Fisons Plc | Propellant compositions |
US6123924A (en) * | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
-
1992
- 1992-09-22 IL IL10323892A patent/IL103238A/en not_active IP Right Cessation
- 1992-09-22 NZ NZ244439A patent/NZ244439A/en not_active IP Right Cessation
- 1992-09-23 DE DE69207606T patent/DE69207606T3/de not_active Expired - Lifetime
- 1992-09-23 EP EP92308657A patent/EP0534731A1/en active Pending
- 1992-09-23 AT AT92920611T patent/ATE132739T1/de active
- 1992-09-23 ES ES92920611T patent/ES2082507T5/es not_active Expired - Lifetime
- 1992-09-23 JP JP05505930A patent/JP3142136B2/ja not_active Expired - Fee Related
- 1992-09-23 AU AU26471/92A patent/AU654397B2/en not_active Expired
- 1992-09-23 DK DK92920611T patent/DK0605578T4/da active
- 1992-09-23 HU HU9400853A patent/HUT67480A/hu unknown
- 1992-09-23 WO PCT/GB1992/001749 patent/WO1993005765A1/en active IP Right Grant
- 1992-09-23 CZ CZ94695A patent/CZ282506B6/cs not_active IP Right Cessation
- 1992-09-23 BR BR9206549A patent/BR9206549A/pt not_active Application Discontinuation
- 1992-09-23 MY MYPI92001697A patent/MY108309A/en unknown
- 1992-09-23 KR KR1019940700969A patent/KR100275426B1/ko not_active IP Right Cessation
- 1992-09-23 UA UA94005331A patent/UA41873C2/ru unknown
- 1992-09-23 EP EP92920611A patent/EP0605578B2/en not_active Expired - Lifetime
- 1992-09-23 RO RO94-00492A patent/RO114735B1/ro unknown
- 1992-09-23 SK SK340-94A patent/SK279456B6/sk not_active IP Right Cessation
- 1992-09-23 CA CA002119932A patent/CA2119932C/en not_active Expired - Lifetime
- 1992-09-23 RU RU94022269/14A patent/RU2122852C1/ru active
- 1992-09-25 CN CN92112491A patent/CN1050285C/zh not_active Expired - Lifetime
- 1992-09-25 MX MX9205483A patent/MX9205483A/es unknown
- 1992-09-29 TW TW081107686A patent/TW216442B/zh not_active IP Right Cessation
-
1994
- 1994-03-24 NO NO941077A patent/NO307124B1/no not_active IP Right Cessation
- 1994-03-24 BG BG98681A patent/BG61752B1/bg unknown
- 1994-03-25 FI FI941388A patent/FI110407B/fi not_active IP Right Cessation
-
1995
- 1995-03-20 HU HU95P/P00090P patent/HU210818A9/hu unknown
-
1996
- 1996-02-23 GR GR960400518T patent/GR3019098T3/el unknown
-
1998
- 1998-05-29 HK HK98104659A patent/HK1005564A1/xx not_active IP Right Cessation
-
1999
- 1999-12-10 GR GR990403193T patent/GR3032103T3/el unknown
-
2000
- 2000-07-13 US US09/616,069 patent/US6641800B1/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94022269A (ru) | Состав аэрозоля, находящийся под давлением | |
ES2001512A6 (es) | Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico | |
DK278288A (da) | Frigivelsessystem til laegemiddel ved anvendelse i mundhulen og en fremgangsmaade til fremstilling af dette frigivelsesystem | |
TW216442B (en) | Pressurised aerosol compositions | |
CA2009890A1 (en) | Valproic acid | |
HRP20000867B1 (en) | Pharmaceutical formulations for aerosols with two or more active substances | |
FI956228A0 (fi) | Sisäänhengitykseen tarkoitettuja koostumuksia | |
DE69231994D1 (de) | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen | |
DK0616524T3 (da) | Lægemidler | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
RS49803B (sr) | Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa | |
DE69333187D1 (de) | Oberflächenaktivmittelfreie Aerosolformulierungen enthaltend Beclomethasondipropionat | |
ES2110212T3 (es) | Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion. | |
HUP9603489A2 (hu) | Gyógyszerkészítmény és eljárás előállítására | |
JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
ES2174388T3 (es) | Solucion liquida de medicamento para administracion oral. | |
JPS5750914A (en) | Betamethasone external pharmaceutical | |
WO1999024016A8 (en) | Emulsions for aerosolization and drug delivery | |
KR950016756A (ko) | 피로회복제 조성물 | |
KR890000472A (ko) | 화합물 | |
JPH02304017A (ja) | ヘアスプレー組成物 | |
KR950016757A (ko) | 약물중독 치료제 조성물 | |
SE9601483L (sv) | Beredning av komposition | |
RU93027376A (ru) | Получение таблетки, содержащей интерферон-альфа, для энтерального применения и ее состав |